These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12511589)

  • 1. A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen.
    Harris TO; Shelver DW; Bohnsack JF; Rubens CE
    J Clin Invest; 2003 Jan; 111(1):61-70. PubMed ID: 12511589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptococcus agalactiae CspA is a serine protease that inactivates chemokines.
    Bryan JD; Shelver DW
    J Bacteriol; 2009 Mar; 191(6):1847-54. PubMed ID: 19114481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing.
    Takahashi S; Nagano Y; Nagano N; Hayashi O; Taguchi F; Okuwaki Y
    Infect Immun; 1995 Dec; 63(12):4764-9. PubMed ID: 7591133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cpsD, a gene essential for type III capsule expression in group B streptococci.
    Rubens CE; Heggen LM; Haft RF; Wessels MR
    Mol Microbiol; 1993 May; 8(5):843-55. PubMed ID: 8355611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci.
    Wessels MR; Haft RF; Heggen LM; Rubens CE
    Infect Immun; 1992 Feb; 60(2):392-400. PubMed ID: 1309720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae.
    Kim JO; Romero-Steiner S; Sørensen UB; Blom J; Carvalho M; Barnard S; Carlone G; Weiser JN
    Infect Immun; 1999 May; 67(5):2327-33. PubMed ID: 10225891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fibrinogen receptor from group B Streptococcus interacts with fibrinogen by repetitive units with novel ligand binding sites.
    Schubert A; Zakikhany K; Schreiner M; Frank R; Spellerberg B; Eikmanns BJ; Reinscheid DJ
    Mol Microbiol; 2002 Oct; 46(2):557-69. PubMed ID: 12406229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcal pyrogenic exotoxin B cleaves properdin and inhibits complement-mediated opsonophagocytosis.
    Tsao N; Tsai WH; Lin YS; Chuang WJ; Wang CH; Kuo CF
    Biochem Biophys Res Commun; 2006 Jan; 339(3):779-84. PubMed ID: 16329996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
    Holzer TJ; Edwards KM; Gewurz H; Mold C
    J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
    Butko P; Nicholson-Weller A; Wessels MR
    J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrc of Streptococcus pneumoniae suppresses capsule expression and enhances anti-phagocytosis.
    Yamaguchi M; Minamide Y; Terao Y; Isoda R; Ogawa T; Yokota S; Hamada S; Kawabata S
    Biochem Biophys Res Commun; 2009 Dec; 390(1):155-60. PubMed ID: 19799870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood.
    Santi I; Scarselli M; Mariani M; Pezzicoli A; Masignani V; Taddei A; Grandi G; Telford JL; Soriani M
    Mol Microbiol; 2007 Feb; 63(3):754-67. PubMed ID: 17212592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptococcus gordonii FSS2 Challisin affects fibrin clot formation by digestion of the αC region and cleavage of the N -terminal region of the Bβ chains of fibrinogen.
    Harty DW; Farahani RM; Simonian MR; Hunter L; Hunter N
    Thromb Haemost; 2012 Aug; 108(2):236-46. PubMed ID: 22552295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence.
    Maisey HC; Quach D; Hensler ME; Liu GY; Gallo RL; Nizet V; Doran KS
    FASEB J; 2008 Jun; 22(6):1715-24. PubMed ID: 18198218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PepN is a non-essential, cell wall-localized protein that contributes to neutrophil elastase-mediated killing of Streptococcus pneumoniae.
    Nganje CN; Haynes SA; Qabar CM; Lent RC; Bou Ghanem EN; Shainheit MG
    PLoS One; 2019; 14(2):e0211632. PubMed ID: 30707714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human neutrophils kill Streptococcus pneumoniae via serine proteases.
    Standish AJ; Weiser JN
    J Immunol; 2009 Aug; 183(4):2602-9. PubMed ID: 19620298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of lysozyme-like protein on virulence and capsular polysaccharide synthesis of Streptococcus pneumoniae].
    Huang J; Jiang X; Huang M; Yangi X; Liu M; Wang H; Meng J
    Wei Sheng Wu Xue Bao; 2011 Jan; 51(1):59-65. PubMed ID: 21465790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affects of N-terminal variation in the SeM protein of Streptococcus equi on antibody and fibrinogen binding.
    Timoney JF; DeNegri R; Sheoran A; Forster N
    Vaccine; 2010 Feb; 28(6):1522-7. PubMed ID: 20005857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
    Givner LB
    Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.